ALNYLAM PHARMACEUTICALS, INC. Retained Earnings 2009-2025 | ALNY
Beta
What is retained earnings?
Retained earnings represent the cumulative net income that has been reinvested in the business rather than distributed as dividends to shareholders.
What is ALNYLAM PHARMACEUTICALS, INC.'s current retained earnings?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual retained earnings for 2025 was $-6.70B, a 8.03% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. retained earnings for the quarter ending December 31, 2025 was $-6.70B.
What was ALNYLAM PHARMACEUTICALS, INC.'s retained earnings in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual retained earnings for 2024 was $-7.29B, a 3.97% decline from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s retained earnings in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual retained earnings for 2023 was $-7.01B, a 6.70% decline from 2022.
Retained Earnings History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$-4.59B
→
FY2025
$-6.70B
0910111213141516171819202122232425
5 years selected
Retained Earnings History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-6.70B | +8.0% | 10-K |
| FY2024 | $-7.29B | -4.0% | 10-K |
| FY2023 | $-7.01B | -6.7% | 10-K |
| FY2022 | $-6.57B | -20.8% | 10-K |
| FY2021 | $-5.44B | -18.6% | 10-K |
| FY2020 | $-4.59B | -23.0% | 10-K |
| FY2019 | $-3.73B | -31.2% | 10-K |
| FY2018 | $-2.84B | -32.3% | 10-K |
| FY2017 | $-2.15B | -29.6% | 10-K |
| FY2016 | $-1.66B | -32.9% | 10-K |
| FY2015 | $-1.25B | -30.3% | 10-K |
| FY2014 | $-956.6M | -60.4% | 10-K |
| FY2013 | $-596.2M | -17.6% | 10-K |
| FY2012 | $-507.0M | -26.4% | 10-K |
| FY2011 | $-401.0M | -16.8% | 10-K |
| FY2010 | $-343.3M | -14.5% | 10-K |
| FY2009 | $-299.8M | - | 10-K |
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →